Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii
Key Finding
Demonstrated LL-37's ability to induce antibiotic sensitization in drug-resistant bacteria, offering a novel strategy for combating antimicrobial resistance.
Key Takeaways
- LL-37 made drug-resistant bacteria vulnerable to antibiotics again.
- Instead of needing new drugs, this peptide could revive existing ones.
- This is a creative new weapon against antibiotic-resistant superbugs.
Study Breakdown
Antimicrobial resistance in Acinetobacter baumannii represents a growing threat in hospital settings worldwide. This study by Lee, Hong, and Ko investigated whether LL-37, a naturally occurring antimicrobial peptide, could influence antibiotic susceptibility in this notoriously drug-resistant bacterium.
The researchers exposed Acinetobacter baumannii to LL-37 and then assessed changes in the bacteria's susceptibility to colistin, one of the last-resort antibiotics used against multidrug-resistant infections. This approach explored whether LL-37 could serve as a sensitizing agent that makes resistant bacteria vulnerable to existing antibiotics.
The results demonstrated that LL-37 effectively induced colistin dependence in Acinetobacter baumannii, meaning the bacteria became sensitized to antibiotic treatment after exposure to the peptide. This finding reveals a novel strategy for overcoming antimicrobial resistance by using natural peptides to restore the effectiveness of conventional antibiotics.
For the fight against antimicrobial resistance, this study offers a creative therapeutic approach. Rather than developing entirely new antibiotics, LL-37 could potentially be used alongside existing drugs to restore their efficacy against resistant pathogens, representing an innovative direction in infectious disease management.
Read the full study on PubMed for complete methodology, data, and citations.
View Full Study on PubMedPMID: 32019695
About LL-37
The only human cathelicidin antimicrobial peptide, playing a critical role in innate immune defense against bacterial, viral, and fungal infections while modulating inflammatory responses.
Learn more about LL-37 →More LL-37 Research
Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications
Voronko OE, Khotina VA, Kashirskikh DA, et al. — International journal of molecular sciences · 2025 Aug 21
The LL-37 domain: A clue to cathelicidin immunomodulatory response?
Leite ML, Duque HM, Rodrigues GR, et al. — Peptides · 2023 Jul
Antibiofilm properties of cathelicidin LL-37: an in-depth review
Memariani H, Memariani M — World journal of microbiology & biotechnology · 2023 Feb 14
LL-37 Triggers Antimicrobial Activity in Human Platelets
Sanchez-Pena FJ, Romero-Tlalolini MLA, Torres-Aguilar H, et al. — International journal of molecular sciences · 2023 Feb 1
Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent
Vera-Cruz A, Tanphaichitr N, Angel JB — Clinical and investigative medicine. Medecine clinique et experimentale · 2021 Oct 3
Interested in how this research applies to your health goals?
Consult Dr. TaylorDisclaimer: This summary is for educational purposes only and is not medical advice. The study breakdown is a simplified overview of the published research. For complete methodology and data, refer to the original publication on PubMed. Always consult with a qualified healthcare provider before making medical decisions.